| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18497512 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 103 journal articles in the PubMed database | Email to a friend | | |
| Hartmann JT, Pintoffl JP, Kroning H, et al.
Gefitinib in Combination with Oxaliplatin and 5-Fluorouracil in Irinotecan-Refractory Patients with Colorectal Cancer: A Phase I Study of the Arbeits gemeinschaft Internistische Onkologie (AIO). [JOURNAL ARTICLE]
Onkologie 2008; 31(5):237-241.
Abstract | Full Citation | Find Related Articles | | Hofheinz RD, Kubicka S, Wollert J, et al.
Gefitinib in Combination with 5-Fluorouracil (5-FU)/Folinic Acid and Irinotecan in Patients with 5-FU/Oxaliplatin- Refractory Colorectal Cancer: A Phase I/II Study of the Arbeitsgemeinschaft für Internistische Onkologie (AIO). [Journal Article]
Onkologie 2006 Dec; 29(12):563-7.
Abstract | Full Citation | | Comella P, Casaretti R, De Rosa V, et al.
Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies. [Clinical Trial, Clinical Trial, Phase I, Journal Article]
Ann Oncol 2002 Dec; 13(12):1874-81.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Cals L, Rixe O, François E, et al.
Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients. [Clinical Trial, Clinical Trial, Phase III, Journal Article]
Ann Oncol 2004 Jul; 15(7):1018-24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kuo T, Cho CD, Halsey J, et al.
Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
J Clin Oncol 2005 Aug 20; 23(24):5613-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gkioulbasanis I, Souglakos J, Vardakis N, et al.
Dose escalating clinical study of high dose infusional 5-fl uorouracil and leukovorin (AIO regimen) plus alternate weekly administration of oxaliplatin and irinotecan in patients with advanced tumors of the gastrointestinal tract. [Journal Article]
J BUON 2007 Apr-Jun; 12(2):197-202.
Abstract | Full Citation | Find Related Articles | | Stickel F, Jüngert B, Brueckl V, et al.
Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin. [Journal Article]
Anticancer Drugs 2003 Oct; 14(9):745-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Yoshino T, Boku N, Onozawa Y, et al.
Efficacy and Safety of an Irinotecan plus Bolus 5-Fluorouracil and L-Leucovorin Regimen for Metastatic Colorectal Cancer in Japanese Patients: Experience in a Single Institution in Japan. [JOURNAL ARTICLE]
Jpn J Clin Oncol 2007 Aug 24.
Abstract | Full Citation | Find Related Articles | | Kwon HC, Oh SY, Lee S, et al.
Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study. [Journal Article]
World J Gastroenterol 2007 Dec 14; 13(46):6231-5.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
New! 